Loading
Latest filing published 07 Jun 2021 for Verrica Pharmaceuticals Inc., €41k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Our data holds just one disclosure by A. Brian Davis, dated 7 June 2021, reporting an open-market purchase worth €41k in Verrica Pharmaceuticals Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration